NHS releases telehealth app to 3.5M Londoners

Cara Livernois | | Health Exec | Telehealth

The National Health Service (NHS) of the United Kingdom has released a free, 24-hour telehealth service administered through a user’s smartphone. The application initially covers 3.5 million patients in London.

The GP at Hand app, developed by the online healthcare provider Babylon, allows patients to check symptoms and book an online appointment that connects patients to providers within two hours.

"It's high time that NHS patients were given the opportunity to benefit from technology to improve access to healthcare,” said Mobasher Butt, a researcher on the team behind GP at Hand. "We've benefited from this kind of technology in so many different aspects of our lives, whether that be shopping or banking, and it's really time that we were able to do that in healthcare for NHS patients."

Read the full story below:

NHS offers smartphone GP appointments

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Related Content

Amazon One Medical sued after patient prescribed inhaler dies in ER
DEA, HHS extend telehealth controlled substance prescription rule
Association of 300 telehealth groups urges Congress to extend COVID-era rules
Eli Lilly releases cheaper, single-use vials of weight loss drug
Walmart sells virtual care business to Fabric
AMA will aggressively support permanent telemedicine reimbursement

Around the web

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met. 

AI in Healthcare
Healthcare AI regulation needs nuance, balance: Research review

When regulating AI-equipped medical devices, the FDA might take a page from the Department of Transportation’s playbook for overseeing AI-equipped vehicles. These run the gamut from assisting human drivers to fully taking the wheel.